Cargando…

The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomy

OBJECTIVE: The objective of this study was to compare the CAPRA-S score (based on clinicopathological findings) and the subtypes of minimal residual disease (MRD) (based on the biological properties of cancer cells) to predict biochemical failure (BF) after prostatectomy radical. PATIENTS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murray, Nigel P, Aedo, Socrates, Fuentealba, Cynthia, Reyes, Eduardo, Salazar, Anibal, Guzman, Eghon, Orrego, Shenda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373647/ https://www.ncbi.nlm.nih.gov/pubmed/32728379 http://dx.doi.org/10.3332/ecancer.2020.1063

Ejemplares similares

The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
por: Murray, Nigel P, et al.
Publicado: (2020)

Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2019)

Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone
por: Murray, Nigel P, et al.
Publicado: (2020)

Minimum Residual Disease in Patients Post Radical Prostatectomy for Prostate Cancer: Theoretical Considerations, Clinical Implications and Treatment Outcome
por: Murray, Nigel P, et al.
Publicado: (2018)

Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse
por: Murray, Nigel P, et al.
Publicado: (2019)

10 Year Biochemical Failure Free Survival of Men with CD82 Positive Primary Circulating Prostate Cells Treated by Radical Prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2018)

Immune Dysfunction as Measured by the Systemic Immune-Inflammation Index is Associated with the Sub-Type of Minimal Residual Disease and Outcome in Stage II Colon Cancer Treated with Surgery alone
por: Murray, Nigel P, et al.
Publicado: (2021)

Combining the Prostate Cancer Risk Index (PRIX) with the Presence of Secondary Circulating Prostate Cells to Predict the Risk of Biochemical Failure after Radical Prostatectomy for Prostate Cancer
por: Murray, Nigel P, et al.
Publicado: (2018)

Outcome of radical prostatectomy in primary circulating prostate cell negative prostate cancer
por: Murray, Nigel P, et al.
Publicado: (2016)

Increasing Immune Dysfunction is Associated with Increasing Matrix-Metalloproteinase-2 Expression and Predicts Biochemical Failure in Men with Bone Marrow Micro-Metastasis Positive Localized Prostate Cancer
por: Murray, Nigel P, et al.
Publicado: (2022)

Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells
por: Murray, Nigel P, et al.
Publicado: (2019)

The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy
por: Murray, Nigel P, et al.
Publicado: (2018)

Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S
por: Pan, Jiahua, et al.
Publicado: (2019)

Management of mild congenital deficiency of Factor XI with a Factor XI inhibitor in pregnancy: A clinical case
por: Murray, Nigel P., et al.
Publicado: (2022)

Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease
por: Murray, Nigel P., et al.
Publicado: (2013)

Deep Neural Networks Outperform the CAPRA Score in Predicting Biochemical Recurrence After Prostatectomy
por: Sargos, Paul, et al.
Publicado: (2021)

The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance
por: Murray, Nigel P, et al.
Publicado: (2017)

Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy
por: Sandeman, Kevin, et al.
Publicado: (2020)

Improvement in the Neutrophil-Lymphocyte Ratio after Combined Fluorouracil, Leucovorina and Oxaliplatino based (FOLFOX) Chemotherapy for Stage III Colon Cancer is Associated with Improved Minimal Residual Disease and Outcome
por: Murray, Nigel P, et al.
Publicado: (2022)

Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy
por: Fujimura, Tetsuya, et al.
Publicado: (2017)

Cancer of the Prostate Risk Assessment (CAPRA) Preoperative Score Versus Postoperative Score (CAPRA-S): Ability to Predict Cancer Progression and Decision-Making Regarding Adjuvant Therapy after Radical Prostatectomy
por: Seo, Won Ik, et al.
Publicado: (2014)

The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy
por: Post, Jennifer M., et al.
Publicado: (2011)

Predictive factors for biochemical recurrence in radical prostatectomy patients
por: Turk, Hakan, et al.
Publicado: (2015)

Prediction of biochemical recurrence after laparoscopic radical prostatectomy
por: Bejrananda, Tanan, et al.
Publicado: (2023)

Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S)
por: Karagiotis, Theodoros, et al.
Publicado: (2022)

Prognostic Factors for the Development of Biochemical Recurrence after Radical Prostatectomy
por: Kotb, Ahmed F., et al.
Publicado: (2011)

Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes
por: Kwon, Ohseong, et al.
Publicado: (2014)

Biochemical recurrence after radical prostatectomy: what does it mean?
por: Tourinho-Barbosa, Rafael, et al.
Publicado: (2018)

Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy
por: Falagario, Ugo Giovanni, et al.
Publicado: (2023)

Renal infarction associated with asymptomatic Covid-19 infection
por: Murray, Nigel P, et al.
Publicado: (2021)

Robot-assisted radical prostatectomy has lower biochemical recurrence than laparoscopic radical prostatectomy: Systematic review and meta-analysis
por: Lee, Seon Heui, et al.
Publicado: (2017)

AB083. Anatomical landmarks for minimally invasive radical prostatectomy
por: Hong, Sung-Hoo
Publicado: (2015)

Impact of capsular incision on biochemical recurrence after radical perineal prostatectomy
por: Kwak, K W, et al.
Publicado: (2009)

The Effect of Tumor-Prostate Ratio on Biochemical Recurrence after Radical Prostatectomy
por: Cho, Sung Yong, et al.
Publicado: (2016)

The Prognostic Factors of Biochemical Recurrence-Free Survival Following Radical Prostatectomy
por: Chalieopanyarwong, Virote, et al.
Publicado: (2017)

MRI Characteristics Accurately Predict Biochemical Recurrence after Radical Prostatectomy
por: Manceau, Cécile, et al.
Publicado: (2020)

Are Diabetic Patients at Increased Risk for Biochemical Recurrence After Radical Prostatectomy?
por: Ben Hadj Alouane, Houssem, et al.
Publicado: (2022)

Role of lymphatic invasion in predicting biochemical recurrence after radical prostatectomy
por: Chung, Dae Hyuk, et al.
Publicado: (2023)

Deltamethrin Residues in Milk and Cheese of Lactating Goats (Capra hircus)
por: Marrone, Raffaele, et al.
Publicado: (2019)

Minimizing complications during retropubic radical prostatectomy - is ureteral stenting necessary?
por: Schlenker, B, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_pch3hajt1irgf7vcsa493u7ic5